Subscribe to our newsletter
Delivering the Future
of Medicine
We are a global contract testing, development and manufacturing organization, (CTDMO). We enable the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies. Our services and solutions accelerate time to market and support customer programs around the world. Our vision is that one day, every drug can be made, and every disease can be treated.
Learn More About Us
Innovative and Transformative Services
For more than 20 years, we have been working with pioneers in advanced therapies to help them successfully discover, develop, manufacture and release their products for patient use.
Contract Testing
Proven analytical method development, lot release testing, viral clearance, stability, and more.
Learn More
Process Development
Expert and flexible approaches to develop, scale, and optimize your processes and methods.
Learn More
IND Enabling Studies
Optimize processes, ensure GMP readiness, and secure data required for your IND submission.
Learn More
Clinical Manufacturing
Phase appropriate approaches that accelerate timelines and ensure quality clinical production.
Learn More
Commercial Manufacturing
High-quality, high-volume capacity, infrastructure, logistics, and systems which have passed inspection.
Learn More
Our
Capabilities
Expertise
Facilities
Quality
Regulatory
Supply Chain
Modalities and Therapeutic Areas
Our experience and services cover CAR-T, T-Cell, TIL, MSC, AAV, Lenti, mAbs, Vaccines and other common advanced therapies.
Autologous
Allogeneic
Monoclonal Antibodies
Vaccines
Viral Vectors
Articles & Events
Minaris Advanced Therapies launches as the leading global partner dedicated to cell therapy development, manufacturing, and testing
New company unveiled at the annual ISCT conference in New Orleans combines two tenured and innovative CDMOs with a testing powerhouse PHILADELPHIA — May 7, 2025 — Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi Advanced Therapies have been combined to form […]
